RxDoctor Payments Data

Rulong Ren, MD

Anatomic Pathology & Clinical Pathology · New Castle, INNPI 1588685481

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations.

$410in general payments, 2019–2025

Across 23 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$83
  • AstraZeneca$50
  • Boston Scientific$42
  • Accord Healthcare, Inc.$31
  • Clarus Therapeutics Inc.$28
  • Myriad Genetic Laboratories, Inc.$27
  • plus $149 from 8 others

What the payments were for

  • Food & beverage$410100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$410 in reported general payments places this provider in the 80th percentile of 137 anatomic pathology & clinical pathology providers in Indiana.

See all anatomic pathology & clinical pathology providers in Indiana

Medicare billing

Part B allowed, 2024
$117,124
Medicare patients
1,621
Services billed
3,416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in New Castle

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →